VIRTUAL LINK:

Microsoft Teams Need help?

Join the meeting now

Meeting ID: 228 425 321 513 44

Passcode: En7zm3HR

Dial in by phone

+1 469-208-1641,,762085492# United States, Carrollton

Find a local number

Phone conference ID: 762 085 492#

Join on a video conferencing device

Tenant key: [email protected]

Video ID: 119 321 198 1

More info

For organizers: Meeting options | Reset dial-in PIN

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1. Discuss the basic understanding of the role for Pulmonary Function Testing in obstructive lung disease and how to interpret those tests.
2. Review basic therapy of asthma as presented in the GINA guidelines.
3. Review basic therapy of COPD as presented in the GOLD guidelines and compare to asthma therapy.

FACULTY DISCLOSURE: Dr. Perkins was a speaker for GSK.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.